The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese; Ho Seong Han; Boram Lee; Hae Won Lee; Jai Young Cho; Roberto Ivan Troisi

doi:10.20517/2394-5079.2022.14

The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese
, Ho Seong Han
, Boram Lee
, Hae Won Lee
, Jai Young Cho
, Roberto Ivan Troisi

Research output: Contribution to journal › Review article › peer-review

Abstract

Liver surgery is the first-line treatment for hepatocellular carcinoma (HCC). Minimally invasive liver resection (MILS) has become an attractive option thanks to reduced intraoperative blood losses, shortened length of hospital stay, and similar oncological outcomes when compared to open liver resection. Nonetheless, the safety of MILS is still debated in challenging situations, such as in cirrhotic patients, difficult tumor locations, multiple or large tumors, and repeat resection. The aim of this review is to discuss current indications of laparoscopic liver resection for HCC treatment in the light of its outcomes, focusing on technical aspects of minimally invasive anatomic liver resection and state of the art of MILS in challenging situations.

Original language	English
Article number	26
Journal	Hepatoma Research
Volume	8
DOIs	https://doi.org/10.20517/2394-5079.2022.14
Publication status	Published - 2022
Externally published	Yes

Keywords

Laparoscopic liver resection
anatomic liver resection
hepatocellular carcinoma
minimally invasive liver surgery

Access to Document

10.20517/2394-5079.2022.14

Cite this

@article{6a097996f7af4c8ca6b40c626c823103,

title = "The role of minimally invasive surgery in the treatment of HCC",

abstract = "Liver surgery is the first-line treatment for hepatocellular carcinoma (HCC). Minimally invasive liver resection (MILS) has become an attractive option thanks to reduced intraoperative blood losses, shortened length of hospital stay, and similar oncological outcomes when compared to open liver resection. Nonetheless, the safety of MILS is still debated in challenging situations, such as in cirrhotic patients, difficult tumor locations, multiple or large tumors, and repeat resection. The aim of this review is to discuss current indications of laparoscopic liver resection for HCC treatment in the light of its outcomes, focusing on technical aspects of minimally invasive anatomic liver resection and state of the art of MILS in challenging situations.",

keywords = "Laparoscopic liver resection, anatomic liver resection, hepatocellular carcinoma, minimally invasive liver surgery",

author = "Gianluca Cassese and Han, \{Ho Seong\} and Boram Lee and Lee, \{Hae Won\} and Cho, \{Jai Young\} and Troisi, \{Roberto Ivan\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

doi = "10.20517/2394-5079.2022.14",

language = "English",

volume = "8",

journal = "Hepatoma Research",

issn = "2394-5079",

publisher = "OAE Publishing Inc.",

}

TY - JOUR

T1 - The role of minimally invasive surgery in the treatment of HCC

AU - Cassese, Gianluca

AU - Han, Ho Seong

AU - Lee, Boram

AU - Lee, Hae Won

AU - Cho, Jai Young

AU - Troisi, Roberto Ivan

N1 - Publisher Copyright: © The Author(s) 2022.

PY - 2022

Y1 - 2022

N2 - Liver surgery is the first-line treatment for hepatocellular carcinoma (HCC). Minimally invasive liver resection (MILS) has become an attractive option thanks to reduced intraoperative blood losses, shortened length of hospital stay, and similar oncological outcomes when compared to open liver resection. Nonetheless, the safety of MILS is still debated in challenging situations, such as in cirrhotic patients, difficult tumor locations, multiple or large tumors, and repeat resection. The aim of this review is to discuss current indications of laparoscopic liver resection for HCC treatment in the light of its outcomes, focusing on technical aspects of minimally invasive anatomic liver resection and state of the art of MILS in challenging situations.

AB - Liver surgery is the first-line treatment for hepatocellular carcinoma (HCC). Minimally invasive liver resection (MILS) has become an attractive option thanks to reduced intraoperative blood losses, shortened length of hospital stay, and similar oncological outcomes when compared to open liver resection. Nonetheless, the safety of MILS is still debated in challenging situations, such as in cirrhotic patients, difficult tumor locations, multiple or large tumors, and repeat resection. The aim of this review is to discuss current indications of laparoscopic liver resection for HCC treatment in the light of its outcomes, focusing on technical aspects of minimally invasive anatomic liver resection and state of the art of MILS in challenging situations.

KW - Laparoscopic liver resection

KW - anatomic liver resection

KW - hepatocellular carcinoma

KW - minimally invasive liver surgery

UR - https://www.scopus.com/pages/publications/85130722896

U2 - 10.20517/2394-5079.2022.14

DO - 10.20517/2394-5079.2022.14

M3 - Review article

SN - 2394-5079

VL - 8

JO - Hepatoma Research

JF - Hepatoma Research

M1 - 26

ER -

The role of minimally invasive surgery in the treatment of HCC

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this